These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8776242)

  • 1. The second-trimester fetus with Down syndrome: detection using sonographic features.
    Benacerraf BR
    Ultrasound Obstet Gynecol; 1996 Feb; 7(2):147-55. PubMed ID: 8776242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonographic scoring index for prenatal detection of chromosomal abnormalities.
    Benacerraf BR; Neuberg D; Bromley B; Frigoletto FD
    J Ultrasound Med; 1992 Sep; 11(9):449-58. PubMed ID: 1283415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of fetuses with short femur length detected at second-trimester anomaly scan: a national survey.
    Mathiesen JM; Aksglaede L; Skibsted L; Petersen OB; Tabor A;
    Ultrasound Obstet Gynecol; 2014 Aug; 44(2):160-5. PubMed ID: 24357398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of second-trimester fetuses with autosomal trisomy by use of a sonographic scoring index.
    Benacerraf BR; Nadel A; Bromley B
    Radiology; 1994 Oct; 193(1):135-40. PubMed ID: 8090881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Echographic measuring of the length of the fetal femur in the screening for Down syndrome].
    Biagiotti R; Periti E; Cariati E; Nannini R
    Minerva Ginecol; 1992 Dec; 44(12):609-12. PubMed ID: 1491768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humeral shortening in second-trimester fetuses with Down syndrome.
    Benacerraf BR; Neuberg D; Frigoletto FD
    Obstet Gynecol; 1991 Feb; 77(2):223-7. PubMed ID: 1824870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does gender have an impact on the sonographic detection of second-trimester fetuses with Down's syndrome?
    Benacerraf BR; Miller WA; Nadel A; Pauker S; Bromley B
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):30-3. PubMed ID: 7850586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal sonographic findings in 207 fetuses with trisomy 21.
    Papp C; Bán Z; Szigeti Z; Csaba A; Lázár L; Nagy GR; Papp Z
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):186-90. PubMed ID: 17029755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of ultrasonographic screening for Down syndrome in the second trimester].
    Bessho T; Taira S; Sawai H; Komori S; Koyama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):115-20. PubMed ID: 7706851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal detection of trisomy 21 by second-trimester ultrasound examination and maternal age in a non-selected population of 49 314 births in Norway.
    Offerdal K; Blaas HG; Eik-Nes SH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):493-500. PubMed ID: 18688793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis?
    Bromley B; Doubilet P; Frigoletto FD; Krauss C; Estroff JA; Benacerraf BR
    Obstet Gynecol; 1994 May; 83(5 Pt 1):647-51. PubMed ID: 8164918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry.
    Verdin SM; Economides DL
    Br J Obstet Gynaecol; 1998 Jan; 105(1):63-7. PubMed ID: 9442164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic identification of second-trimester fetuses with Down's syndrome.
    Benacerraf BR; Gelman R; Frigoletto FD
    N Engl J Med; 1987 Nov; 317(22):1371-6. PubMed ID: 2960895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of fetal intracardiac echogenic foci in relation to trisomy 21: a prospective sonographic study of high-risk pregnant women.
    Manning JE; Ragavendra N; Sayre J; Laifer-Narin SL; Melany ML; Grant EG; Crandall BF
    AJR Am J Roentgenol; 1998 Apr; 170(4):1083-4. PubMed ID: 9530064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the second trimester genetic sonogram in screening for fetal Down syndrome.
    Benacerraf BR
    Semin Perinatol; 2005 Dec; 29(6):386-94. PubMed ID: 16533652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography.
    Vintzileos AM; Egan JF
    Am J Obstet Gynecol; 1995 Mar; 172(3):837-44. PubMed ID: 7892872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.